Researchers Find Immunotherapy Drug May Treat Pheochromocytoma

Those diagnosed with paraganglioma-pheochromocytoma, squamous cell carcinoma of the skin (cSCC), adrenocortical carcinoma (ACC), and carcinoma of unknown primary (CUP) may soon have an additional option for treatment. According to…

Continue Reading Researchers Find Immunotherapy Drug May Treat Pheochromocytoma
New Treatment for Pheochromocytoma and Paraganglioma Approved by the FDA
valelopardo / Pixabay

New Treatment for Pheochromocytoma and Paraganglioma Approved by the FDA

According to a story from globenewswire.com, the company Progenic Pharmaceuticals recently reported the the U.S. Food and Drug Administration has recently approved the company's product iobenguane I 131 (AZEDRA). This…

Continue Reading New Treatment for Pheochromocytoma and Paraganglioma Approved by the FDA
Data Shows Radiotherapy Drug is Effective and Safe for Patients With Pheochromocytoma and Paraganglioma
source: pixabay.com

Data Shows Radiotherapy Drug is Effective and Safe for Patients With Pheochromocytoma and Paraganglioma

According to a story from news-medical.net, the results of a recent research trial demonstrate that the radiation therapy drug AZEDRA (ultratrace iobenguane I131) is an effective and safe treatment option…

Continue Reading Data Shows Radiotherapy Drug is Effective and Safe for Patients With Pheochromocytoma and Paraganglioma
Close Menu